Schedule 13D ownership disclosure

Orchestra BioMed Holdings Inc

Common Stock, par value $0.0001 per share · CUSIP: 68572M106

Event date: 2025-08-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LPReported CIK 0001493215

    Shares: 8,306,063.00 · Class: 15.4%

  • RTW Master Fund, Ltd.Reported CIK 0001493219

    Shares: 4,394,985.00 · Class: 8.1%

  • RTW Innovation Master Fund, Ltd.Reported CIK 0001776733

    Shares: 3,053,082.00 · Class: 5.7%

  • Roderick WongReported CIK 0001493280

    Shares: 8,306,063.00 · Class: 15.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021175
Form type
SCHEDULE 13D/A
Filer
Orchestra BioMed Holdings, Inc.
CIK
CIK 1814114
Filed
Aug 06, 2025
Reporting period
Aug 04, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub